Interest is high in improving quality control for clinical metabolomics: setting the path forward for community harmonization of quality control standards

Towards quality assurance and quality control in untargeted metabolomics studies

(2019) Richard D. Beger et al.   Metabolomics

Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies

(2018) David Broadhurst et al.   Metabolomics

Quality assurance and quality control processes: summary of a metabolomics community questionnaire

(2017) Warwick B. Dunn et al.   Metabolomics

Development and Application of Ultra-Performance Liquid Chromatography-TOF MS for Precision Large Scale Urinary Metabolic Phenotyping

(2016) Matthew R. Lewis et al.   ANALYTICAL CHEMISTRY

Metabolomics enables precision medicine: “A White Paper, Community Perspective”

(2016) Richard D. Beger et al.   Metabolomics

The New Data Quality Task Group (DQTG): ensuring high quality data today and in the future

(2014) Daniel W. Bearden et al.   Metabolomics

Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology

(2013) R Kaddurah-Daouk et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry

(2011) Warwick B Dunn et al.   Nature Protocols

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

(2009) T. A. Clayton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reproducible and reliable microarray results through quality control: good laboratory proficiency and appropriate data analysis practices are essential

(2008) Leming Shi et al.   CURRENT OPINION IN BIOTECHNOLOGY